These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15998776)

  • 1. Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function.
    Marthinet E; Bloc A; Oka Y; Tanizawa Y; Wehrle-Haller B; Bancila V; Dubuis JM; Philippe J; Schwitzgebel VM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5401-6. PubMed ID: 15998776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Cartier EA; Conti LR; Vandenberg CA; Shyng SL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2882-7. PubMed ID: 11226335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of a novel member of the ATP-sensitive K+ channel subunit family, Kir6.3, in zebrafish.
    Zhang C; Miki T; Shibasaki T; Yokokura M; Saraya A; Seino S
    Physiol Genomics; 2006 Feb; 24(3):290-7. PubMed ID: 16317080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a familial hyperinsulinism-causing mutation in the sulfonylurea receptor 1 that prevents normal trafficking and function of KATP channels.
    Taschenberger G; Mougey A; Shen S; Lester LB; LaFranchi S; Shyng SL
    J Biol Chem; 2002 May; 277(19):17139-46. PubMed ID: 11867634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destabilization of ATP-sensitive potassium channel activity by novel KCNJ11 mutations identified in congenital hyperinsulinism.
    Lin YW; Bushman JD; Yan FF; Haidar S; MacMullen C; Ganguly A; Stanley CA; Shyng SL
    J Biol Chem; 2008 Apr; 283(14):9146-56. PubMed ID: 18250167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and pharmacological correction of a membrane trafficking defect associated with a mutation in the sulfonylurea receptor causing familial hyperinsulinism.
    Partridge CJ; Beech DJ; Sivaprasadarao A
    J Biol Chem; 2001 Sep; 276(38):35947-52. PubMed ID: 11457841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
    Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
    Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
    Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
    Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.
    Otonkoski T; Ammälä C; Huopio H; Cote GJ; Chapman J; Cosgrove K; Ashfield R; Huang E; Komulainen J; Ashcroft FM; Dunne MJ; Kere J; Thomas PM
    Diabetes; 1999 Feb; 48(2):408-15. PubMed ID: 10334322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy.
    Shyng SL; Ferrigni T; Shepard JB; Nestorowicz A; Glaser B; Permutt MA; Nichols CG
    Diabetes; 1998 Jul; 47(7):1145-51. PubMed ID: 9648840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
    Hosy E; Dérand R; Revilloud J; Vivaudou M
    J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
    Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
    J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of {beta}-cell ATP-sensitive potassium channels.
    Yan FF; Lin CW; Cartier EA; Shyng SL
    Am J Physiol Cell Physiol; 2005 Nov; 289(5):C1351-9. PubMed ID: 15987767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population.
    Reimann F; Huopio H; Dabrowski M; Proks P; Gribble FM; Laakso M; Otonkoski T; Ashcroft FM
    Diabetologia; 2003 Feb; 46(2):241-9. PubMed ID: 12627323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
    Muzyamba M; Farzaneh T; Behe P; Thomas A; Christesen HB; Brusgaard K; Hussain K; Tinker A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):115-24. PubMed ID: 17466004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro recovery of ATP-sensitive potassium channels in β-cells from patients with congenital hyperinsulinism of infancy.
    Powell PD; Bellanné-Chantelot C; Flanagan SE; Ellard S; Rooman R; Hussain K; Skae M; Clayton P; de Lonlay P; Dunne MJ; Cosgrove KE
    Diabetes; 2011 Apr; 60(4):1223-8. PubMed ID: 21411514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
    Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
    J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
    Masia R; Enkvetchakul D; Nichols CG
    J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.